This website will not work correctly in Internet Explorer 11 and it is strongly recommended that you upgrade to an up-to-date browser. Internet Explorer 11 will go out of support and be retired on June 15, 2022. For more information on upgrading please see browser-update.org.
A £45 million partnership between the Wellcome Trust and the Department of Biotechnology, Government of India, is unveiled today to support the development of innovative…
The Wellcome Trust and Merck & Co., Inc. announce the creation of the MSD-Wellcome Trust Hilleman Laboratories, a unique research and development joint venture with a not…
A large clinical trial comparing treatments for typhoid has recommended the use of gatifloxacin, an affordable new-generation antibiotic. The results of the trial in…
A roadmap to making lifesaving monoclonal antibody treatments affordable and available, particularly to those living in low- and middle-income countries.
Any Covid-19 vaccines, tests and treatments developed should benefit the whole world. We are working with the ACT-Accelerator and other international partners to make sure…
The way we tackle infectious diseases is largely led by countries and organisations in the global north, competition and profit. How can we create a better research and…
Researchers may well identify a safe, effective vaccine for COVID-19 before too long, but all that fantastic work could count for nothing unless we also invest in the next…
A YouGov poll, commissioned by Wellcome, reveals that 9 in 10 people (90%) in the UK say COVID-19 treatments and vaccines should first be provided for those who need them…
The government’s proposed reforms to the National Health Service lack a clear vision of what a 21st-century health service should deliver, according to the Director of the…
Ensuring the people who most need access to vaccines and effective treatments against Covid-19, wherever they are in the world, is supported by almost 9 in 10 German adults.
Alexander Pym, an infectious disease expert with experience across academia, clinical settings and industry, will lead Wellcome’s work on infectious disease, supporting…